1. Home
  2. MOD vs PRAX Comparison

MOD vs PRAX Comparison

Compare MOD & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modine Manufacturing Company

MOD

Modine Manufacturing Company

HOLD

Current Price

$266.17

Market Cap

13.1B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$329.90

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOD
PRAX
Founded
1916
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
9.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MOD
PRAX
Price
$266.17
$329.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
15
Target Price
$223.71
$572.13
AVG Volume (30 Days)
815.5K
315.1K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
12.87
N/A
EPS
0.90
N/A
Revenue
$1,352,500,000.00
N/A
Revenue This Year
$23.05
N/A
Revenue Next Year
$21.83
$7,758.26
P/E Ratio
$283.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$86.48
$34.89
52 Week High
$260.01
$354.87

Technical Indicators

Market Signals
Indicator
MOD
PRAX
Relative Strength Index (RSI) 63.89 51.96
Support Level $125.19 $282.49
Resistance Level N/A $353.83
Average True Range (ATR) 13.54 19.33
MACD -0.03 -1.74
Stochastic Oscillator 93.84 42.19

Price Performance

Historical Comparison
MOD
PRAX

About MOD Modine Manufacturing Company

Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: